Molecule Details
| InChIKey | FDLHDUZIGJCBAK-WRLVAQMBSA-N |
|---|---|
| Compound Name | (9R,17S,20S,23R,26S)-9-[[(2R)-2-acetamidohexanoyl]amino]-23-[3-(diaminomethylideneamino)propyl]-20-(1H-indol-3-ylmethyl)-26-(naphthalen-2-ylmethyl)-8,11,19,22,25,28-hexaoxo-7,12,18,21,24,27-hexazaspiro[5.22]octacosane-17-carboxamide |
| Canonical SMILES | CCCC[C@@H](NC(C)=O)C(=O)N[C@@H]1CC(=O)NCCCC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)C2(CCCCC2)NC1=O |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 8.05 |
| Source | ChEMBL |
2D Structure
Activity Profile